{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:07:18Z","timestamp":1781197638844,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007027","name":"Leon Levy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New York State Department of Health Empire Clinical Research Investigator Program"},{"name":"Florence Gould Foundation"},{"name":"The Society of Interventional Radiology Foundation"},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS097443"],"award-info":[{"award-number":["R01NS097443"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS095869"],"award-info":[{"award-number":["U01NS095869"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS105948"],"award-info":[{"award-number":["K23NS105948"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Michael Goldberg Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1U01NS080824"],"award-info":[{"award-number":["1U01NS080824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U24TR001609"],"award-info":[{"award-number":["U24TR001609"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01NS080824"],"award-info":[{"award-number":["U01NS080824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12028-020-01081-4","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T21:04:04Z","timestamp":1597698244000},"page":"983-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Liver Fibrosis and Perihematomal Edema Growth in Primary Intracerebral Hemorrhage"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8802-2380","authenticated-orcid":false,"given":"Neal S.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Jesudian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy C.","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh B.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the VISTA-ICH Collaboration","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. F.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. R.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11940-018-0486-5","volume":"20","author":"TJ Cusack","year":"2018","unstructured":"Cusack TJ, Carhuapoma JR, Ziai WC. Update on the treatment of spontaneous intraparenchymal hemorrhage: medical and interventional management. Curr Treat Options Neurol. 2018;20:1.","journal-title":"Curr Treat Options Neurol"},{"key":"1081_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jama.2019.2413","volume":"321","author":"BA Gross","year":"2019","unstructured":"Gross BA, Jankowitz BT, Friedlander RM. Cerebral intraparenchymal hemorrhage: a review. JAMA J Am Med Assoc. 2019;321:1295\u2013303.","journal-title":"JAMA J Am Med Assoc"},{"key":"1081_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrneurol.2014.264","volume":"11","author":"S Urday","year":"2015","unstructured":"Urday S, Kimberly WT, Beslow LA, et al. Targeting secondary injury in intracerebral haemorrhage\u2013perihaematomal oedema. Nat Rev Neurol. 2015;11:111\u201322.","journal-title":"Nat Rev Neurol"},{"key":"1081_CR4","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1161\/STROKEAHA.115.010054","volume":"46","author":"SB Murthy","year":"2015","unstructured":"Murthy SB, Moradiya Y, Dawson J, et al. Perihematomal edema and functional outcomes in intracerebral hemorrhage: influence of hematoma volume and location. Stroke. 2015;46:3088\u201392.","journal-title":"Stroke"},{"key":"1081_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/CCM.0000000000002831","volume":"46","author":"EM Liotta","year":"2018","unstructured":"Liotta EM, Romanova AL, Lizza BD, et al. Osmotic shifts, cerebral edema, and neurologic deterioration in severe hepatic encephalopathy. Crit Care Med. 2018;46:280\u20139.","journal-title":"Crit Care Med"},{"key":"1081_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11011-010-9172-3","volume":"25","author":"J C\u00f3rdoba","year":"2010","unstructured":"C\u00f3rdoba J, Garc\u00eda-Martinez R, Sim\u00f3n-Talero M. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis. 2010;25:73\u201380.","journal-title":"Metab Brain Dis"},{"key":"1081_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-0038-1676954","volume":"119","author":"S Bos","year":"2019","unstructured":"Bos S, van den Boom B, Kamphuisen PW, et al. Haemostatic profiles are similar across all aetiologies of cirrhosis. Thromb Haemost. 2019;119:246\u201353.","journal-title":"Thromb Haemost"},{"key":"1081_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00535-007-2060-x","volume":"42","author":"M Yoneda","year":"2007","unstructured":"Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol. 2007;42:573\u201382.","journal-title":"J Gastroenterol"},{"key":"1081_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/MEG.0000000000001393","volume":"31","author":"T Khoury","year":"2019","unstructured":"Khoury T, Mari A, Nseir W, Kadah A, Sbeit W, Mahamid M. Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2019;31:1110\u20135.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1138\u201345","key":"1081_CR10","first-page":"e5","volume":"16","author":"L Caballer\u00eda","year":"2018","unstructured":"Caballer\u00eda L, Pera G, Arteaga I, et al. High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study. Clin Gastroenterol Hepatol. 2018;16(1138\u201345):e5.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"968\u201375","key":"1081_CR11","first-page":"e5","volume":"17","author":"GP Watt","year":"2019","unstructured":"Watt GP, Lee M, Pan JJ, et al. High prevalence of hepatic fibrosis, measured by elastography,\u00a0in a population-based study of Mexican Americans. Clin Gastroenterol Hepatol. 2019;17(968\u201375):e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1081_CR12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1136\/gut.2010.221382","volume":"60","author":"D Roulot","year":"2011","unstructured":"Roulot D, Costes JL, Buyck JF, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut. 2011;60:977\u201384.","journal-title":"Gut"},{"key":"1081_CR13","doi-asserted-by":"publisher","first-page":"e007241","DOI":"10.1161\/CIRCIMAGING.117.007241","volume":"11","author":"MR Ostovaneh","year":"2018","unstructured":"Ostovaneh MR, Ambale-Venkatesh B, Fuji T, et al. Association of liver fibrosis with cardiovascular diseases in the general population: the multi-ethnic study of atherosclerosis (MESA). Circ Cardiovasc Imaging. 2018;11:e007241.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1081_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/STROKEAHA.119.028161","volume":"51","author":"NS Parikh","year":"2020","unstructured":"Parikh NS, Kamel H, Navi BB, et al. Liver fibrosis indices and outcomes after primary intracerebral hemorrhage. Stroke. 2020;51:830\u20137.","journal-title":"Stroke"},{"key":"1081_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1747-4949.2011.00735.x","volume":"7","author":"M Ali","year":"2012","unstructured":"Ali M, Bath P, Brady M, et al. Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke. 2012;7:133\u20138.","journal-title":"Int J Stroke"},{"key":"1081_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ajg.2017.5","volume":"112","author":"MN Kabbany","year":"2017","unstructured":"Kabbany MN, Conjeevaram Selvakumar PK, Watt K, et al. Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: an analysis of national health and nutrition examination survey data. Am J Gastroenterol. 2017;112:581\u20137.","journal-title":"Am J Gastroenterol"},{"key":"1081_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726\u201336.","journal-title":"Hepatology"},{"key":"1081_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","volume":"30","author":"BK Kim","year":"2010","unstructured":"Kim BK, Kim DY, Park JY, et al. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int. 2010;30:546\u201353.","journal-title":"Liver Int"},{"key":"1081_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.22576","volume":"49","author":"S Naveau","year":"2009","unstructured":"Naveau S, Gaud\u00e9 G, Asnacios A, et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology. 2009;49:97\u2013105.","journal-title":"Hepatology"},{"key":"1081_CR20","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66:1486\u2013501.","journal-title":"Hepatology"},{"key":"1081_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u201325.","journal-title":"Hepatology"},{"key":"1081_CR22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/jnnp-2016-313653","volume":"87","author":"SB Murthy","year":"2016","unstructured":"Murthy SB, Urday S, Beslow LA, et al. Rate of perihaematomal oedema expansion is associated with poor clinical outcomes in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 2016;87:1169\u201373.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1081_CR23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/STROKEAHA.114.007565","volume":"46","author":"S Urday","year":"2015","unstructured":"Urday S, Beslow LA, Goldstein DW, et al. Measurement of perihematomal edema in intracerebral hemorrhage. Stroke. 2015;46:1116\u20139.","journal-title":"Stroke"},{"key":"1081_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/STROKEAHA.116.016016","volume":"48","author":"NS Parikh","year":"2017","unstructured":"Parikh NS, Merkler AE, Schneider Y, Navi BB, Kamel H. Discharge disposition after stroke in patients with liver disease. Stroke. 2017;48:476\u20138.","journal-title":"Stroke"},{"key":"1081_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2176\/nmc.52.181","volume":"52","author":"K Hoya","year":"2012","unstructured":"Hoya K, Tanaka Y, Uchida T, et al. Intracerebral hemorrhage in patients with chronic liver disease. Neurol Med Chir (Tokyo). 2012;52:181\u20135.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1081_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00415-017-8451-x","volume":"264","author":"A Morotti","year":"2017","unstructured":"Morotti A, Marini S, Lena UK, et al. Significance of admission hypoalbuminemia in acute intracerebral hemorrhage. J Neurol. 2017;264:905\u201311.","journal-title":"J Neurol"},{"key":"1081_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jcrc.2017.06.002","volume":"41","author":"M Di Napoli","year":"2017","unstructured":"Di Napoli M, Behrouz R, Topel CH, et al. Hypoalbuminemia, systemic inflammatory response syndrome, and functional outcome in intracerebral hemorrhage. J Crit Care. 2017;41:247\u201353.","journal-title":"J Crit Care"},{"key":"1081_CR28","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017;112:740\u201351.","journal-title":"Am J Gastroenterol"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-01081-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-020-01081-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-01081-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:08:57Z","timestamp":1629158937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-020-01081-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1007\/s12028-020-01081-4","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Parikh, Dr. Jesudian, Dr. Murthy: none. Hooman Kamel serves as the co-PI for the NIH-funded ARCADIA trial which receives in-kind study drug from the BMS-Pfizer Alliance and in-kind study assays from Roche Diagnostics, serves as a steering committee member of Medtronic\u2019s Stroke AF trial (uncompensated), serves on an endpoint adjudication committee for a trial of empagliflozin for Boehringer Ingelheim, and has served on an advisory board for Roivant Sciences related to Factor XI inhibition. Dr. Hanley reports personal fees from Op2Lysis, personal fees from BrainScope, personal fees from Neurotrope, and non-financial support from Genentech outside the submitted work. Dr, Ziai receives consulting fees from C.R. Bard, Inc., and Portola Pharmaceuticals, Inc., outside of the area of work commented on here.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Trials included in the VISTA-ICH cohort were performed with institutional review board and\/or regulatory approval, and our analysis was approved by the Weill Cornell Medicine Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}